Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02303470 · ClinicalTrials.gov registry record · NA
PCOS & Insulin Resistance Exercise Study
A NA study of Insulin Resistance and Polycystic Ovary Syndrome, sponsored by University of California, San Francisco.
- Active
- Registry status
- NA
- Development phase
- 47
- Enrollment target
- 1
- Study location
NCT02303470: Active NA study of Insulin Resistance and Polycystic Ovary Syndrome, sponsored by University of California, San Francisco.
NCT02303470 is a NA study of Insulin Resistance and Polycystic Ovary Syndrome that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 47 participants, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02303470, a NA study of Insulin Resistance and Polycystic Ovary Syndrome, is active but no longer recruiting, sponsored by University of California, San Francisco.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the feasibility and metabolic effects of implementing a structured exercise program in women with polycystic ovary syndrome and insulin resistance. Participants will be randomized to either 75 minutes of vigorous exercise or 150 minutes of moderate exercise per week.
Conditions Studied
Interventions
- BEHAVIORAL Vigorous Exercise
- BEHAVIORAL Moderate Exercise
Study Locations (1)
California
- UCSF Center for Reproductive Health - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2015-03 |
| Est. Completion | 2025-02 |
| Phase | NA |
What the registry record for NCT02303470 still lists
NCT02303470 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 47 participants, a relatively small participant target, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (81% lower).
The record links to 2 conditions, with Insulin Resistance appearing as the primary indexed condition, and to 2 interventions - of which Vigorous Exercise is the first listed.
NCT02303470 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02303470 about?
NCT02303470 is a clinical study titled "PCOS & Insulin Resistance Exercise Study". This study evaluates the feasibility and metabolic effects of implementing a structured exercise program in women with polycystic ovary syndrome and insulin resistance. Participants will be randomized to either 75 minutes of vigorous exercise or 150 minutes of moderate exercise per week.
What is the current status of trial NCT02303470?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 47 participants. The study started on 2015-03. Estimated completion is 2025-02.
What conditions does trial NCT02303470 study?
This clinical trial studies the following conditions: Insulin Resistance, Polycystic Ovary Syndrome.
What interventions are being tested in trial NCT02303470?
The interventions under investigation include: Vigorous Exercise (BEHAVIORAL), Moderate Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT02303470?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02303470 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insulin Resistance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02303470's enrollment target sits among peer trials
47 64th of 120 higher than 56 of 120 other Insulin Resistance trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Insulin Resistance trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
RECRUITING · NA
-
Small Extracellular Vesicles and Insulin Action
RECRUITING · NA
-
Exercise Effects on Adipose Tissue Structure and Function
RECRUITING · NA
-
New Mechanisms of Obesity
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03313011 · 47 participants
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
- NCT03467516 · 47 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
- NCT03886662 · 47 participants · Phase 1
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- NCT04013802 · 47 participants · Phase 1
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia